In dynamic market segments such as the public and private payers, data and syndicated market research age rapidly and must be carefully tested and verified to provide a reliable basis for business planning. Strategyx regularly synthesizes complex market data and qualitative segment decision-maker input into action-oriented strategies and supporting tactics that help clients develop solid business relationships and product access. Our long-standing presence in the managed market segments provides unparalleled access to decision-makers whose actions will define the profitability of products and therapeutics across the US. We maintain a continuously updated database of nearly 5,000 key decision makers in Managed Markets organizations across all geographies.

Strategyx maintains productive consultative relationships with health care decision-makers and subject matter experts throughout Europe. These relationships allow us to:

• Access resources to pull the most relevant information for our projects
• Conduct research with experts and decision-makers in local languages and different settings
• Gain the perspective of clinical and business decision-makers, key opinion leaders, customers, and subject matter experts

Strategyx' Decision-Maker Advisory Council (DMAC) is a unique methodology for harnessing target customers' experience and energy in a cooperative attempt to help you develop solutions for a business issue.

• Attendance goes beyond the traditional customers to a deliberately chosen mix of decision-makers with the qualifications to solve the problems brought to them
• Meeting design, with its well-structured sessions of small groups and focused content, provides a unique experience for participants
• Techniques for brainstorming and problem solving are specifically chosen to increase participation, to help new ideas emerge and to develop scenarios or models by building on other participants' contributions
• Moderators are seasoned healthcare and pharmaceutical industry professionals who have credibility with participants

The Complex Message - Assessment and Research (CMAR) methodology combines primary market research tools with a consultative information-delivery approach to engage specialty audiences in comprehensive brand positioning discussions.

• Individual, web-assisted presentations of compelling clinical, pharmacoeconomic and competitor data result in feedback and assessment of the value proposition, including needs for supportive data or value-added programs
• Engages key therapeutic area opinion leaders or payer decision- makers in comprehensive brand position discussions to develop buy-in and "ownership"
• Clarifies and fits the message to the customer's perspective ensuring product value is not just communicated but perceived and experienced